Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and BMC for ACL Reconstruction Healing
NCT04205656Phase 2Active, not recruiting
- Sponsor
- Steadman Philippon Research Institute
- Start
- Jan 2020
- Primary completion
- Jul 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Leukocyte-Poor Platelet Rich Plasma, autologous bone marrow cell concentrate in anterior cruciate ligament injury, sponsored by Steadman Philippon Research Institute. Started Jan 2020; status: active, not recruiting.
02
Drugs
Leukocyte-Poor Platelet Rich Plasmaautologous bone marrow cell concentrate
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT04205656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205656.